FindMyKOL
Clinical trialNCT04410406CompletedPhase 3Interventional

Moxidectin for LF, Cote d'Ivoire (DOLF)

SponsorWashington University School of MedicineEnrollment164Lymphatic Filariasis
View the registry record on ClinicalTrials.gov

Summary

The lay summary the sponsor registered on ClinicalTrials.gov.

The purpose of this study is to determine whether moxidectin (Mox) will be more effective than ivermectin (IVM) when used in single-dose combination therapies for lymphatic filariasis (LF).
clinicaltrials.gov ↗

Investigators

The overall officials registered on this study. Names that resolve to a FindMyKOL profile link to it; the rest are shown as registered.

  • Benjamin Koudou, PhD

    Regional Hospital of Agboville, Southern Cote d'Ivoire

    Principal Investigator
    clinicaltrials.gov ↗
  • Catherine Bjerum, MD, MPH

    Case Western Reserve University

    Principal Investigator
    clinicaltrials.gov ↗
  • Philip Budge, MD, PhD

    Washington University School of Medicine

    Principal Investigator
    clinicaltrials.gov ↗
  • Toki Pascal Gabo, MD

    Regional Hospital of Agboville, Southern Cote d'Ivoire

    Principal Investigator
    clinicaltrials.gov ↗

A profile link is shown only when the registered name resolves to a person record with a confident, namesake-checked match; ambiguous names stay unlinked.

Sites

1 registered facility, with the per-site recruitment status where the registry publishes one. ClinicalTrials.gov does not publish per-site enrollment counts.

Côte d’Ivoire
  • Regional Hospital of Agboville, Southern Cote D'Ivoire

    Agboville, Côte d’Ivoire

Site investigator names are published by ClinicalTrials.gov only while a study recruits, so completed studies list sites without them.

Drugs studied

The drug and biological interventions registered on this study, normalized to their RxNorm ingredient where possible.

AlbendazoleDiethylcarbamazineIvermectin →Moxidectin
Linked drugs open the directory filtered to KOLs working with them.clinicaltrials.gov ↗

Registration & key dates

Registry attributes as recorded on the ClinicalTrials.gov study record.

Start
20 Aug 2020
Primary completion
1 Oct 2024
Completion
1 Oct 2024
Last update posted
29 Jan 2026
Registered enrollment
164
Registry id
NCT04410406
clinicaltrials.gov ↗

Source: ClinicalTrials.gov, via the CTTI AACT database, data as of 24 Aug 2026. Registry facts are shown as registered by the study sponsor; FindMyKOL does not interpret them.